Since the announcement of the deal, Sobi has also seen its Gamifant (emapalumab-lzsg), a treatment for primary hemophagocytic lymphohistiocytosis (HLH), approved by the FDA. HLH is caused by hyper ...
Sobi has been building its immunology pipeline (rare-disease drug Gamifant, US rights to RSV antibodies Synagis and Beyfortus, gout drug SEL-212, complement drug Aspaveli) and a broader hematology ...
As of 2:32:52 PM GMT+1. Market Open. Loading Chart for SOBI.ST ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback